Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 4-oxo-N-(4-hydroxyphenyl)retinamide derivatives as therapeutic agents for the treatment of cancer

4-oxo-N-(4-hydroxyphenyl)retinamide derivatives as therapeutic agents for the treatment of cancer

US Patent 10093621 · Granted Oct 9, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Retinoid derivatives with antitumor activity2023
Retinoid derivatives with antitumor activity2022
Retinoid derivatives with antitumor activity2021
Retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties2013
Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activitie2012
Biphenyl and Naphthyl-Phenyl Hydroxamic Acid Derivatives2010
Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents2010
7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antago2009
Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activitie2008
7-imino derivatives of camptothecin having antitumor activity2008
Camptothecin derivatives having antitumor activity2006